343 related articles for article (PubMed ID: 23776375)
1. Inherited and acquired alterations in development of breast cancer.
Rizzolo P; Silvestri V; Falchetti M; Ottini L
Appl Clin Genet; 2011; 4():145-58. PubMed ID: 23776375
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic pathways in hereditary and sporadic breast cancer.
Kenemans P; Verstraeten RA; Verheijen RH
Maturitas; 2004 Sep; 49(1):34-43. PubMed ID: 15351094
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic pathways in hereditary and sporadic breast cancer.
Kenemans P; Verstraeten RA; Verheijen RH
Maturitas; 2008; 61(1-2):141-50. PubMed ID: 19434886
[TBL] [Abstract][Full Text] [Related]
4. Hereditary breast cancer; Genetic penetrance and current status with BRCA.
Mahdavi M; Nassiri M; Kooshyar MM; Vakili-Azghandi M; Avan A; Sandry R; Pillai S; Lam AK; Gopalan V
J Cell Physiol; 2019 May; 234(5):5741-5750. PubMed ID: 30552672
[TBL] [Abstract][Full Text] [Related]
5. A new paradigm of genetic testing for hereditary breast/ovarian cancers.
Kwong A; Chen JW; Shin VY
Hong Kong Med J; 2016 Apr; 22(2):171-7. PubMed ID: 26980575
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic factors in breast cancer therapy.
Mathur R; Jha NK; Saini G; Jha SK; Shukla SP; Filipejová Z; Kesari KK; Iqbal D; Nand P; Upadhye VJ; Jha AK; Roychoudhury S; Slama P
Front Genet; 2022; 13():886487. PubMed ID: 36212140
[TBL] [Abstract][Full Text] [Related]
7. Pathology of hereditary breast cancer.
van der Groep P; van der Wall E; van Diest PJ
Cell Oncol (Dordr); 2011 Apr; 34(2):71-88. PubMed ID: 21336636
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
9. Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis.
Chan TA; Glockner S; Yi JM; Chen W; Van Neste L; Cope L; Herman JG; Velculescu V; Schuebel KE; Ahuja N; Baylin SB
PLoS Med; 2008 May; 5(5):e114. PubMed ID: 18507500
[TBL] [Abstract][Full Text] [Related]
10. [Molecular basis of hereditary cancers].
Tímár J
Magy Onkol; 2020 Mar; 64(1):7-11. PubMed ID: 32181757
[TBL] [Abstract][Full Text] [Related]
11. Hereditary breast cancer: from molecular pathology to tailored therapies.
Tan DS; Marchiò C; Reis-Filho JS
J Clin Pathol; 2008 Oct; 61(10):1073-82. PubMed ID: 18682420
[TBL] [Abstract][Full Text] [Related]
12. Women at high risk of breast cancer: Molecular characteristics, clinical presentation and management.
Kleibl Z; Kristensen VN
Breast; 2016 Aug; 28():136-44. PubMed ID: 27318168
[TBL] [Abstract][Full Text] [Related]
13. Genetic susceptibility to cancer. ICRP publication 79. Approved by the Commission in May 1997. International Commission on Radiological Protection.
Ann ICRP; 1998; 28(1-2):1-157. PubMed ID: 10406427
[TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation in male breast cancer: analysis by multiplex ligation-dependent probe amplification.
Kornegoor R; Moelans CB; Verschuur-Maes AH; Hogenes MCh; de Bruin PC; Oudejans JJ; van Diest PJ
Breast Cancer Res; 2012 Jul; 14(4):R101. PubMed ID: 22765268
[TBL] [Abstract][Full Text] [Related]
15. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.
Yurgelun MB; Kulke MH; Fuchs CS; Allen BA; Uno H; Hornick JL; Ukaegbu CI; Brais LK; McNamara PG; Mayer RJ; Schrag D; Meyerhardt JA; Ng K; Kidd J; Singh N; Hartman AR; Wenstrup RJ; Syngal S
J Clin Oncol; 2017 Apr; 35(10):1086-1095. PubMed ID: 28135145
[TBL] [Abstract][Full Text] [Related]
16. EMSY copy number variation in male breast cancers characterized for BRCA1 and BRCA2 mutations.
Navazio AS; Rizzolo P; Silvestri V; Valentini V; Zelli V; Zanna I; Masala G; Bianchi S; Tommasi S; Palli D; Ottini L
Breast Cancer Res Treat; 2016 Nov; 160(1):181-186. PubMed ID: 27628328
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic reduction of DNA repair in progression to gastrointestinal cancer.
Bernstein C; Bernstein H
World J Gastrointest Oncol; 2015 May; 7(5):30-46. PubMed ID: 25987950
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of the epigenome in triple-negative breast cancers: basal-like and claudin-low breast cancers express aberrant DNA hypermethylation.
Roll JD; Rivenbark AG; Sandhu R; Parker JS; Jones WD; Carey LA; Livasy CA; Coleman WB
Exp Mol Pathol; 2013 Dec; 95(3):276-87. PubMed ID: 24045095
[TBL] [Abstract][Full Text] [Related]
19. Molecular cloning of BRCA1: a gene for early onset familial breast and ovarian cancer.
Bowcock AM
Breast Cancer Res Treat; 1993 Nov; 28(2):121-35. PubMed ID: 8173065
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
